{"id":727714,"date":"2025-01-15T13:04:01","date_gmt":"2025-01-15T13:04:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=727714"},"modified":"2025-01-15T13:04:01","modified_gmt":"2025-01-15T13:04:01","slug":"parenteral-nutrition-market-revenue-to-reach-1360-billion-by-2029-offering-over-5-billion-in-opportunities-in-the-next-6-years-arizton","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/parenteral-nutrition-market-revenue-to-reach-1360-billion-by-2029-offering-over-5-billion-in-opportunities-in-the-next-6-years-arizton_727714.html","title":{"rendered":"Parenteral Nutrition Market Revenue to Reach $13.60 Billion by 2029, Offering Over $5 Billion in Opportunities in the Next 6 Years – Arizton"},"content":{"rendered":"
\n
\"Parenteral<\/a><\/div>\n
\n
Parenteral Nutrition Market Research Report by Arizton<\/div>\n<\/div>\n<\/div>\n

\u202f\u202f<\/p>\n

According to Arizton’s latest research report, the parenteral nutrition market<\/a> is growing at a CAGR of 8.24% during 2023-2029.<\/p>\n

\u202f\u202f\u202f\u202f\u202f<\/p>\n

To Know More, Click: <\/strong>https:\/\/www.arizton.com\/market-reports\/parenteral-nutrition-market<\/strong><\/a><\/p>\n

 <\/p>\n

Report Summary<\/strong>\u202f\u202f\u202f\u202f\u202f\u202f<\/p>\n

Market Size by Consumption (2029): <\/strong>$13.60 Billion<\/p>\n

Market Size by Consumption (2023): <\/strong>$8.46 Billion<\/p>\n

CAGR by Consumption (2023-2029):<\/strong> 8.24%<\/p>\n

Historic Year:<\/strong> 2020-2022<\/p>\n

Base Year:<\/strong> 2023<\/p>\n

Forecast Year:<\/strong> 2024-2029<\/p>\n

Market Segmentation:<\/strong> Product, Nutrition, Patient Group, Indication, End-Users, and Geography<\/p>\n

Geographic Analysis:<\/strong> North America, APAC, Europe, Latin America, and Middle East & Africa<\/p>\n

 <\/p>\n

The global parenteral nutrition (PN) market is experiencing growth driven by the rising prevalence of chronic diseases like cancer and gastrointestinal disorders, an increase in malnutrition cases, and an aging population facing nutrient absorption challenges. Advances in PN formulations, particularly those tailored to meet specific patient needs, have enhanced safety and efficacy, leading to broader adoption. The macronutrient segment, which plays a significant role in PN solutions, has gained prominence due to improvements in formulation stability, safety, and compatibility, making it a key component in both hospital and home care settings. Ready-to-use (RTU) or standard commercial PN has also become a dominant segment, valued for its convenience, safety, and cost-effectiveness.<\/p>\n

Adults represent the largest patient group, with the growing need for PN driven by an increasing number of surgeries and intensive care admissions, where it is crucial for patient recovery. Similarly, short-term PN usage, particularly in acute care settings for patients requiring immediate nutritional support due to surgeries, trauma, or critical illnesses, is expanding.<\/p>\n

Hospitals continue to be the primary end-users of PN solutions, benefiting from the growing demand for nutritional support in both general and specialized care settings.<\/p>\n

 <\/p>\n

Advancements in Research and Development of Parenteral Nutrition Solutions<\/strong><\/p>\n

Research and development (R&D) in parenteral nutrition (PN) is rapidly progressing to create safer, more effective, and highly specialized nutritional solutions. This growth is driven by the need to improve patient outcomes, reduce complications, and enhance the convenience of PN administration across various healthcare settings. A major area of research focuses on refining nutrient compositions, such as innovations in lipid emulsions containing omega-3 fatty acids, which aim to reduce inflammation, support immune function, and prevent complications like parenteral nutrition-associated liver disease (PNALD). Additionally, R&D in micronutrient and trace element formulations ensures that patients, particularly pediatric, critically ill, or long-term PN patients, receive a balanced intake of essential nutrients tailored to their specific needs. Advances in delivery systems are also reshaping the PN landscape, with automated compounding systems allowing for precise mixing of complex formulas, reducing errors and contamination. Portable infusion pumps are improving, making home parenteral nutrition (HPN) more feasible and comfortable for patients who do not need hospitalization. These devices are increasingly integrated with remote monitoring capabilities, enabling healthcare providers to oversee patients’ progress in real-time, detect potential issues early, and adjust treatments as necessary, ensuring safer and more effective nutritional solutions for patients who cannot receive adequate nutrition through traditional routes.<\/p>\n

 <\/p>\n

Boom in Home Care & Long-term Care Settings for Parenteral Nutrition Solutions<\/strong><\/p>\n

The home care and long-term care settings segment in the parenteral nutrition (PN) market is rapidly growing, with a significant increase in demand driven by the rising number of patients with chronic conditions requiring long-term nutritional support. These patients often prefer to manage their conditions outside of hospitals to improve their quality of life and avoid hospital-associated risks like infections. Home care settings provide a more cost-effective solution by reducing the need for extended hospital stays, while long-term care centers, such as nursing homes, are increasingly adopting PN to support an aging population with complex health needs. Elderly patients often face conditions that impair their ability to eat or absorb nutrients, making PN essential for maintaining their health. Both home care and long-term care settings are benefiting from advancements in PN, including simplified administration systems and portable infusion pumps that make it easier to manage care outside of hospitals. However, challenges such as insurance reimbursement, training, and logistical considerations still limit the market share of these settings compared to hospitals. Despite these challenges, the segment is expected to see continued growth, driven by improvements in healthcare services and accessibility.<\/p>\n

 <\/p>\n

APAC to Lead the Parenteral Nutrition Market <\/strong><\/p>\n

The parenteral nutrition (PN) market in the Asia-Pacific (APAC) region is growing rapidly, driven by factors such as the rising prevalence of chronic diseases, an aging population, and increasing awareness of malnutrition’s health impacts. Countries like China, India, and Japan are making significant investments in healthcare infrastructure and improving nutritional health, which is boosting the adoption of PN. Chronic diseases, particularly cancer, diabetes, and gastrointestinal disorders, contribute to malnutrition, creating high demand for PN, especially for cancer patients managing treatment side effects. Additionally, malnutrition is widespread among hospitalized patients in APAC, affecting recovery and extending hospital stays, making PN a vital intervention for at-risk individuals. The high rate of preterm births in the region further drives the demand for PN, as premature infants require specialized nutritional support. As healthcare facilities improve, the neonatal and pediatric PN market is also expanding, contributing to the overall growth of the APAC parenteral nutrition market.<\/p>\n

 <\/p>\n

Buy this Research @<\/strong> https:\/\/www.arizton.com\/market-reports\/parenteral-nutrition-market<\/a><\/p>\n

\u202f<\/p>\n

Key Vendors<\/strong><\/p>\n